Weight loss gets cheaper: New White House deal slashes prices of Ozempic and Wegovy |
The cost of some of the most widely used weight loss medications in the United States is set…
Is Eli Lilly a Millionaire Maker?
Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
Weight-Loss Drug Zepbound Gets Walmart D2C Pricing
Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart…
Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149
The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly LLY 1.15%increase; green up pointing triangle…
Massive sales for weight loss drugs spur Eli Lilly’s Q3
As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…
Eli Lilly says weight-loss pill a candidate for speedy approval under new US program
By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…
Former MD agrees not to disclose information allegedly taken from company, court hears – The Irish Times
A former managing director (MD) of a supplier of materials to the construction industry has agreed not to…
Lilly invests in epigenetic reprogramming biotech
NewLimit adds $45m in new funding at a $1.6bn valuation following preclinical progress that brings clinical trials closer…
Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
LLY’s Oral GLP-1 Pill Scores Another Pair of Diabetes Wins
Eli Lilly LLY announced positive top-line data from two late-stage studies evaluating orforglipron, its once-daily oral GLP-1 pill, in…
1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today
Eli Lilly (NYSE: LLY) has been one of the best-performing healthcare giants over the past decade. It now…
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…